Last reviewed · How we verify
NCT03264196: CHOC1
Condylar Head Operative or Conservative 1
NA trial testing Open Reduction and Internal Fixation in Condylar Process of Mandible Open Fracture in 14 participants. Completed in 30 September 2025.
30 September 2024
Quick facts
| Lead sponsor | Oxford University Hospitals NHS Trust |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 14 |
| Start date | 24 January 2018 |
| Primary completion | 30 September 2024 |
| Estimated completion | 30 September 2025 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Open Reduction and Internal Fixation
Conditions studied
- Condylar Process of Mandible Open Fracture — all drugs for Condylar Process of Mandible Open Fracture →
Sponsor
Oxford University Hospitals NHS Trust
Who can join
Adults 18 to 99, any sex, with Condylar Process of Mandible Open Fracture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The condylar head is the part of the lower jaw which forms the joint. Displaced fractures of this area are uncommon but can cause problems with function, such as chewing, if not treated effectively. The medical literature does not have a clear consensus on whether these should be treated operatively (with surgery to reduce and fix the fracture) or conservatively (with advice and exercise and no surgery). The investigators propose a randomised controlled trial comparing the outcome of the operative or conservative treatment of condylar head fractures of the mandible, primarily with regards to patient related outcome measures of mandibular function, and secondarily objective measures of mandibular movement, function and symptoms to try and provide a clearer answer as to the best way of managing them.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03264196
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Open Reduction and Internal Fixation
Trials testing the same drug.
- NCT03196193 — CM Asia Nail With AS2 Without AS2 （AS2 Study） · NA · completed
- NCT01589692 — A Clinical Trial for the Surgical Treatment of Elderly Distal Radius Fractures · NA · completed
Other Oxford University Hospitals NHS Trust trials
Trials by the same sponsor.
- NCT07303582 — Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities · Phase 4 · recruiting
- NCT06922695 — Responding to AF: Pill-in-Pocket Anticoagulation Guided by Automated Monitoring and Alerts · NA · recruiting
- NCT06822686 — Autologous Stem Cells in the Management of Fistulating Perianal Crohn's Disease · NA · not yet recruiting
- NCT06397664 — The Impact of Chronic Adolescent Skin Conditions on Sexual Health · completed
- NCT06130397 — AI Assisted Detection of Fractures on X-Rays (FRACT-AI) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03264196 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oxford University Hospitals NHS Trust
- Last refreshed: 15 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03264196.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing